Provided by Tiger Trade Technology Pte. Ltd.

InflaRx N.V.

1.72
+0.01000.58%
Post-market: 1.720.00000.00%19:52 EDT
Volume:422.16K
Turnover:738.46K
Market Cap:253.34M
PE:-3.16
High:1.80
Open:1.74
Low:1.72
Close:1.71
52wk High:2.95
52wk Low:0.7984
Shares:147.29M
Float Shares:98.11M
Volume Ratio:1.19
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5449
EPS(LYR):-0.7963
ROE:-38.52%
ROA:-18.54%
PB:1.54
PE(LYR):-2.16

Loading ...

InflaRx to Present Late-Breaking Preclinical Izicopan Data at ASN Kidney Week 2026

Reuters
·
Yesterday

InflaRx Appoints Gabriela Alperovich as SVP, Global Head of Clinical Development

Reuters
·
Oct 01

T-CURX Appoints Florian Schmid CFO

Reuters
·
Sep 30

InflaRx to Host Virtual Capital Markets Day After Timing Shift

Reuters
·
Sep 21

InflaRx Initiated at Buy by Needham

Dow Jones
·
Sep 14

Needham Initiates InflaRx at Buy With $8 Price Target

MT Newswires Live
·
Sep 14

InflaRx Nv : Needham Initiates Coverage with Buy Rating; Target Price $8

THOMSON REUTERS
·
Sep 14

InflaRx to Present at H.C. Wainwright Annual Global Investment Conference

Reuters
·
Aug 20

InflaRx Price Target Raised to $6.00/Share from $4.00 by Cantor Fitzgerald

Dow Jones
·
Aug 07

Analysts’ Top Healthcare Picks: InflaRx (IFRX), CG Oncology, Inc. (CGON)

TIPRANKS
·
Aug 07

InflaRx NV Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

InflaRx Posts H1 Loss as Warrant Fair-Value Hit Outweighs FX Gains, R&D Spending Falls

Reuters
·
Aug 06

InflaRx H1 FY26 Net Loss Narrows to €16.2 Million

Reuters
·
Aug 06

InflaRx Q2 EPS $(0.10) Misses $(0.08) Estimate

Benzinga Earnings
·
Aug 06

Press Release: InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones

Dow Jones
·
Aug 06

InflaRx NV Expected to Post a Loss of 6 Cents a Share - Earnings Preview

Reuters
·
Aug 04

InflaRx to Report Second-quarter Results Before Market Open

Reuters
·
Jul 30

Analysts Offer Insights on Healthcare Companies: InflaRx (IFRX) and Baxter International (BAX)

TIPRANKS
·
Jul 27

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 21

InflaRx (IFRX) Gets a Buy from Oppenheimer

TIPRANKS
·
Jun 30